Maria Arantxa Horga Atea Pharmaceuticals, Inc. (AVIR) insider trading activity

AVIR Quotes by TradingView

Maria Arantxa Horga is Chief Medical Officer of Atea Pharmaceuticals, Inc.. Currently has a direct ownership of 60,876 shares of AVIR, which is worth approximately $181,410. The most recent transaction as insider was on Jan 31, 2025, when has been sold 16,071 shares (Common Stock) at a price of $3.06 per share, resulting in proceeds of $49,177. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.9K
137.2% 3M change
137.2% 12M change
Total Value Held $181,410

Maria Arantxa Horga Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2025
SELL
Payment of exercise price or tax liability
$49,177 $3.06 p/Share
16,071 Reduced 20.89%
60,876 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
9,750 Added 11.25%
76,947 Common Stock
Jan 31 2025
BUY
Exercise of conversion of derivative security
-
41,533 Added 38.2%
67,197 Common Stock
Feb 01 2024
SELL
Open market or private sale
$60,940 $3.84 p/Share
15,870 Reduced 38.21%
25,664 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
41,534 Added 50.0%
41,534 Common Stock
MAH

Maria Arantxa Horga

Chief Medical Officer
Boston, MA

Track Institutional and Insider Activities on AVIR

Follow Atea Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVIR shares.

Notify only if

Insider Trading

Get notified when an Atea Pharmaceuticals, Inc. insider buys or sells AVIR shares.

Notify only if

News

Receive news related to Atea Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AVIR